Functions of serotonin in hypoxic pulmonary vascular remodeling

Cell Biochemistry and Biophysics

Volumn 47, Issue 1, 2007, Pages 33-43

  Esteve, Juan M ^a,b,c   Launay, Jean Marie ^d,e   Kellermann, Odile ^f   Maroteaux, Luc ^a,b,c,g,h  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e AP HP ^*  (France)

^f CNRS   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

Author keywords

Arteries; Cell division; Dexfenfluramine; Hypoxia; Physiopathology; Pulmonary hypertension; Receptor; Serotonin; Transporter; Vascular remodeling

Indexed keywords

MUS;

EID: 34147095275     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:47:1:33     Document Type: Review

References (97)

1. Semenza, G. L. (1999) Perspectives on oxygen sensing. Cell 98, 281-284.
2. Yuan, X.J., Tod, M. L., Rubin, L. J., and Blaustein, M. P. (1990) Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am. J. Physiol, 259, H281-289.
3. Egermayer, P., Town G. I., and Peacock, A. J. (1999) Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 54, 161-168.
4. Villalón, C. M., de Vries, P., and Saxena, P. R. (1997) Serotonin receptors as cardiovascular targets. Drug Discovery Today 2, 294-300.
5. Rubin, L. J. (1999) Cellular and molecular mechanisms responsible for the pathogenesis of primary pulmonary hypertension. Pediatr. Pulmonol. 18(Suppl), 194-197.
6. Rich, S. (2000) Primary pulmonary hypertension. Curr. Treat. Options Cardiovasc. Med. 2, 135-140.
7. Reeves, J. T., Groves B. M., and Turkevich, D. (1986) The case for treatment of selected patients with primary pulmonary hypertension. Am. Rev. Respir. Dis. 134, 342-346.
8. Aaronson, P. I., Robertson T. P., and Ward, J. P. (2002) Endothelium-derived mediators and hypoxic pulmonary vasoconstriction. Respir. Physiol. Neurobiol. 132, 107-120.
9. Novotna, J. and Herget, J. (2002) Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia. Physiol. Res. 51, 323-334.
10. Raymond, J. R., Mukhin, Y. V., Gelasco, A., et al. (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 92, 179-212.
11. Kuang, S., Doran, S. A., Wilson, R. J., Goss G. G., and Goldberg, J. I. (2002) Serotonergic sensory-motor neurons mediate a behavioral response to hypoxia in pond snail embryos. J. Neurobiol. 52, 73-83.
12. Kinkead, R. and Mitchell, G. S. (1999) Time-dependent hypoxic ventilatory responses in rats: effects of ketanserin and 5-carboxamidotryptamine. Am. J. Physiol. 277, R658-666.
13. McGuire, M., Zhang, Y., White, D. P. and Ling, L. (2004) Serotonin receptor subtypes required for ventilatory longterm facilitation and its enhancement after chronic inter-mittent hypoxia in awake rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R334-341.
14. Kirby, G. C. and McQueen, D. S. (1984) Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine. Br. J. Pharmacol. 83, 259-269.
15. Fu, X.W., Nurse, C. A. Wong V., and Cutz, E. (2002) Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit. J. Physiol. 539, 503-510.
16. Farber, H. W. and Loscalzo, J. (2004) Pulmonary arterial hypertension. N. Engl. J. Med. 351, 1655-1665.
17. Hervé, P., Drouet, L., Dosquet, C., et al. (1990) Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med. 89, 117-120.
18. Hervé, P., Launay, J. M., Scrobohaci, M. L., et al. (1995) Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 1995. 99, 249-254.
19. Kéreveur, A., Callebert, J., Humbert, M., et al. (2000) High plasma serotonin levels in primary pulmonary hypertension : effect of long-term epoprostenol (Prostacyclin) therapy. Arterioscler. Thromb. Vasc. Biol. 20, 2233-2239.
20. Kentera, D., Susic, D., Veljkovic, V., Tucakovic, G., and Koko, V. (1988) Pulmonary artery pressure in rats with hereditary platelet function defect. Respiration 54, 110-114.
21. Sato, K., Webb, S., Tucker, A., et al. (1992) Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am. Rev. Respir. Dis. 145, 793-797.
22. Vane, J. R. (1957) A sensitive method for the assay of 5-hydroxytryptamine. Br. J. Pharmacol. Chemother. 12, 344-349.
23. McDonald, T. P., Cottrell, M., and Clift, R. (1978) Effects of short-term hypoxia on platelet counts of mice. Blood 51, 165-175.
24. McDonald, T. P., Cottrell, M. B., Steward, S. A., Clift, R. E., Swearingen C. J., and Jackson, C. W. (1992) Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia. Exp. Hematol. 20, 51-56.
25. Li, N., Wallen, N. H., Ladjevardi, M., and Hjemdahl, P. (1997) Effects of serotonin on platelet activation in whole blood. Blood Coagul. Fibrinolysis 8, 517-523.
26. Rostagno, C., Prisco, D., Boddi, M., and Poggesi, L. (1991) Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Eur. Respir J. 4, 147-151.
27. Steele, P., Ellis, Jr., J. H., Weily, H. S., and Genton, E. (1977) Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation 55, 660-661.
28. Keith, I. M., Will, J. A., Huxtable. R. J., and Weir, K. (1987) Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension. Histol. Histopathol. 2, 203-206.
29. Fanburg, B. L. and Lee, S. L. (2000) A role for the serotonin transporter in hypoxia-induced pulmonary hypertension. J. Clin. Invest. 105, 1521-1523.
30. Cook, E. H., Jr., Fletcher, K. E., Wainwright, M., Marks, N., Yan S. Y., and Leventhal, B. L. (1994) Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J. Neurochem. 63, 465-469.
31. De Chaffoy de Courcelles, D. and De Clerck, F. (1990) The human platelet 5-HT2-receptor: an up-date, in Cardiovascular Pharmacology of 5-Hydroxytryptamine (Saxena, P. R., Wallis, D. I., Wouters, W., and Bevan, P., Eds.). Kluwer, Dordrecht: pp. 445-457.
32. Davidson, C. and Stamford, J. A. (1996) Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptors. Neuropharmacology 35, 1627-1634.
33. Eddahibi, S., Fabre, V., Boni, C., Martres, M. P., Raffestin, B., Hamon M., and Adnot, S. (1999) Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ. Res. 84, 329-336.
34. Bhat, G.B. and Block, E. R. (1990) Hypoxia directly increases serotonin transport by porcine pulmonary artery endothelial cell plasma membrane vesicles. Am. J. Respir. Cell Mol. Biol. 3, 363-367.
35. MacLean, M. R., Deuchar, G. A., Hicks, M.N., et al (2004) Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxiainduced pulmonary hypertension. Circulation 109, 2150-2155.
36. Lee, S. L., Wang, W. W. , Moore, B. J., and Fanburg, B. L. (1991) Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res. 68, 1362-1368.
37. Marcos, E., Adnot, S., Pham, M. H., et al. (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am. J. Respir. Crit. Care Med. 168, 487-493.
38. Pitt, B. R., Weng, W., Steve, A. R., Blakely, R.,D., Reynolds I., and Davies, P. (1994) Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 266, L178-186.
39. Sanchez, C. and Hyttel, J. (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19, 467-489.
40. Morecroft, I., Loughlin, L., Nilsen, M., J. et al. (2005) Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J. Pharmacol. Exp. Ther. 313, 539-548.
41. Ni, W., Wilhelm, C. S., Bader, M., Murphy, D. L., Lookingland K. J., and Watts, S. W. (2005) (+)-Norfen-fluramine-induced arterial contraction is not dependent on endogenous 5-HT or 5-HTT. J. Pharmacol. Exp. Ther. 314, 953-960.
42. Rabinovitch, M. (2001) Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension. J. Clin. Invest. 108,1109-1111.
43. Eddahibi, S., Hanoun, N., Lanfumey, L., et al. (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest. 105, 1555-1562.
44. Jeffery, T. K. and Wanstall, J. C. (2001) Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 92, 1-20.
45. Keegan, A., Morecroft, I., Smillie, D., Hicks M. N., and MacLean, M. R. (2001) Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension. Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935. Circ. Res. 89, 1231-1229.
46. Angeles, D. M., Williams, J., Purdy, R. E., Zhang L., and Pearce, W. J. (2001) Effects of maturation and acute hypoxia on receptor-IP(3) coupling in ovine common carotid arteries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R410-417.
47. Angeles, D. M., Williams, J., Zhang L., and Pearce, W. J. (2000) Acute hypoxia modulates 5-HT receptor density and agonist affinity in fetal and adult ovine carotid arteries. Am. J. Physiol. Heart Circ. Physiol. 279, H502-510.
48. Launay, J. M., Hervé, P., Peoc'h, K., et al. (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat. Med. 2002. 8, 1129-1135.
49. Tournois, C., Mutel, V., Manivet, P., Launay J. M., and Kellermann, O. (1998) Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism. J. Biol. Chem. 273, 17,498-17,503.
50. Launay, J. M., Schneider, B., Loric, S., Da Prada, M. and Kellermann, O. (2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. FASEB J. 20, 1843-1854.
51. Hampl, V. and Herget, J. (2000) Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol. Rev. 80, 1337-1372.
52. Ishida, T., Kawashima, S., Hirata K., and Yokoyama, M. (1998) Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J. Med. Sci. 44, 51-63.
53. Glusa, E. and Pertz, H. H. (2000) Further evidence that 5-HTinduced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors. Br. J. Pharmacol. 130, 692-698.
54. Matsuda, H., Li, Y., and Yoshikawa, M. (2000) Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice. Life Sci. 66, 2233-2238.
55. Miller, K. J. and Gonzalez, H. A. (1998) Serotonin 5-HT2A receptor activation inhibits cytokine-stimulated inducible nitric oxide synthase in C6 glioma cells. Ann. N Y Acad. Sci. 861, 169-173.
56. Fozard, J. R. (1995) The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch. Int. Pharmacodyn. Ther. 329, 111-119.
57. Manivet, P., Mouillet-Richard, S., Callebert , J., et al. (2000) PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J. Biol. Chem. 275, 9324-9331.
58. Grewal, J. S., Mukhin, Y. V., Garnovskaya, M. N., Raymond J. R., and Greene, E. L. (1999) Serotonin 5-HT2A receptor induces TGF-beta1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am. J. Physiol. 276, F922-930.
59. Mossner, R., Dringen, R., Persico, A. M., et al. (2002) Increased hippocampal DNA oxidation in serotonin transporter deficient mice. J. Neural. Transm. 109, 557-565.
60. Pietri, M., Schneider, B., Mouillet-Richard, S., et al. (2005) Reactive oxygen species-dependent TNF-alpha converting enzyme activation trough stimulation of 5-HT2B and alpha1D autoreceptors in neuronal cells. FASEB J. 19, 1078-1087.
61. Nebigil, C. G., Etienne, N., Messaddeq N., and Maroteaux, L. (2003) Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B-receptor signaling. FASEB J. 17, 1373-1375.
62. Blanpain, C., Le Poul, E., Parma, J. et al. (2003) Serotonin 5-HT2B receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension. Cardiovasc. Res. 60, 518-528.
63. Deraet, M., Manivet, P., Janoshazi, A., et al. (2005) The natural mutation encoding a C terminus-truncated 5-Hydroxytryptamine2B receptor is a gain of proliferative functions. Mol. Pharmacol. 67, 983-991.
64. Kitamura, K., Singer, W. D., Star, R. A., Muallem, S., and Miller, R. T. (1996) Induction of inducible nitric-oxide synthase by the heterotrimeric G protein Galpha13. J. Biol. Chem. 271, 7412-7415.
65. Nebigil, C. G., Launay, J.-M., Hickel, P., Tournois, C., and Maroteaux, L. (2000) 5 -Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross talk with tyrosine kinase pathways. Proc. Natl. Acad. Sci. USA 97, 2591-2596.
66. Nagao, M., Kaziro, Y., and Itoh, H. (1999) The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Galpha12. Oncogene 18, 4425-4434.
67. Fagan, K. A., Oka, M., Bauer, N. R., et al. (2004) Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L656-664.
68. Rondelet, B., Van Beneden, R., Kerbaul, F., et al. (2003) Expression of the serotonin 1b receptor in experimental pulmonary hypertension. Eur. Respir. J. 22, 408-412.
69. Abenhaim, L., Moride, Y., Brenot, F., et al. (1996) Appetitesuppressant drugs and the risk of primary pulmonary hypertension. International primary pulmonary hypertension study group. N. Engl. J. Med. 335, 609-616.
70. Fitzgerald, L. W., Burn, T. C., Brown, B. S., et al. (2000) Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. Mol. Pharmacol. 57, 75-81.
71. Rothman, R. B., Baumann, M. H., Savage, J. E., et al. (2000) Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102, 2836-2841.
72. Loscalzo, J. (2001) Genetic clues to the cause of primary pulmonary hypertension. N. Engl. J. Med. 345, 367-371.
73. Frid, M. G., Dempsey, E. C., Durmowicz, A. G., and Stenmark, K. R. (1997) Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler. Thromb. Vasc. Biol. 17, 1203-1209.
74. Lee, S. L., Wang, W. W., Lanzillo, J. J., and Fanburg, B. L. (1994) Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am. J. Physiol. 266, L53-60.
75. Fanburg, B. L. and Lee, S. L. (1997) Anew role for an old molecule: serotonin as a mitogen. Am. J. Physiol. 272, L795-806.
76. Madden, M. C., Vender, R. L., and Friedman, M. (1986) Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins 31, 1049-1062.
77. Rothman, A., Wolner, B., Button D., and Taylor, P. (1994) Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. J. Biol. Chem. 269, 6399-6404.
78. Katayose, D., Ohe, M., Yamauchi, K., et al. (1993) Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am. J. Physiol. 264, L100-106.
79. Perkett, E. A., Pelton, R. W., Meyrick, B., Gold, L. I., and Miller, D. A. (1994) Expression of transforming growth factor-beta mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 11, 16-24.
80. Humbert, M., Monti, G., Brenot, F., et al. (1995) Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151, 1628-1631.
81. Wang, X., Wang, B. R., Duan, X. L., et al. (2002) Strong expression of interleukin-1 receptor type I in the rat carotid body. J. Histochem. Cytochem. 50, 1677-1684.
82. Cooper, A. L. and Beasley, D. (1999) Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. Am. J. Physiol. 277, H1326-1337.
83. Yan, S. F., Tritto, I., Pinsky, D., et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J. Biol. Chem. 270, 11,463-11,471.
84. Jaffré, F., Callebert, J., Sarre, A., et al. (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 110, 969-974.
85. Thompson, K. and Rabinovitch, M. (1996) Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J. Cell Physiol. 166, 495-505.
86. Maruyama, K., Ye, C. L. Woo, M., et al. (1991) Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am. J. Physiol. 261, H1716-1726.
87. Novotna, J. and Herget, J. (1998) Exposure to chronic hypoxia induces qualitative changes of collagen in the walls of peripheral pulmonary arteries. Life Sci. 62, 1-12.
88. Wilcox, B. D., Rydelek-Fitzgerald, L., and Jeffrey, J. J. (1994)Regulation of uterine collagenase gene expression: interactions between serotonin and progesterone. Mol. Cell Endocrinol. 101, 67-75.
89. Semenza, G. L. (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1-3.
90. Zhong, H., De Marzo, A. M., Laughner, E., et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.
91. Semenza, G. L. (2000) Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59, 47-53.
92. Yu, A. Y., Shimoda, L. A., Iyer, N. V., et al. (1999) Semenza, Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J. Clin. Invest. 103, 691-696.
93. Page, E. L., Robitaille, G. A., Pouyssegur, J., and Richard, D. E. (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277, 48,403-48,409.
94. Regula, K. M., Baetz, D., and Kirshenbaum, L. A. (2004) Nuclear factor-kappaB represses hypoxia-induced mitochondrial defects and cell death of ventricular myocytes. Circulation 110, 3795-3802.
95. Matsuda, A., Suzuki, Y., Honda, G., et al. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22, 3307-3318.
96. Hagen, T., Taylor, C. T., Lam, F., and Moncada, S. (2003) Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302, 1975-1978.
97. Machado, R. D., Kochler, R., Glissmeyer, E., et al. (2006) Genetic association of the serotonin transporter in pulmonary arterial hypertension. Am J. Respir. Crit. Care Med. 173, 793-797.